.png)
Outpace Bio
AI-Powered Protein Design for Cell Therapy
Seattle, United States · Founded 2020 · $144.0M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- outpacebio.com
- Total Funding
- $144.0M
- Last Round
- $144.0M Series BAug 2024
- Rounds
- 1
About
Outpace Bio is a Seattle-based biotechnology company using AI-powered protein design to develop next-generation cell therapies targeting solid tumors. Its platform combines de novo protein engineering with cellular engineering to improve the efficacy and safety of CAR-T and other cell therapy products. Founded in 2020, the company raised a $144M Series B in 2024.
Summary
Outpace Bio is an Artificial Intelligence company based in Seattle, United States, founded in 2020. It has raised $144.0M in total across 1 round, most recently a $144.0M Series B round in Aug 2024.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2024
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...